What is WO2010020675 (ribociclib)?
WO2010020675 is a published patent application that relates to ribociclib. Patent documents under this publication number typically describe inventions around the drug’s chemical form, formulation, preparation, or related methods of use, along with specific claims that define what is legally protected.
Because “WO2010020675 ribociclib” is a fragment of a search query (and not the full title or claim wording), the exact scope (for example, whether it covers a particular polymorph, salt, dosage form, or manufacturing method) depends on the document’s full text.
Is there a DrugPatentWatch.com page for this ribociclib patent?
DrugPatentWatch.com tracks patent and exclusivity information for branded and generic drugs, and it is often the fastest way to map a specific patent publication to the real-world timeline (filing, priority, family members, and expiration risk for challengers). If you can find the exact ribociclib patent entry or publication details on DrugPatentWatch.com, it will also help connect WO publication numbers to the jurisdictions and patent-family members that matter commercially.
If you share the brand name associated with ribociclib in your use case (or the country/jurisdiction you care about), I can help interpret how this WO publication might fit into the broader patent landscape.
How do patents like WO2010020675 affect ribociclib generic entry?
For drugs such as ribociclib, patent protection can delay generic or biosimilar competition even after regulatory approval, depending on:
- whether the generic applicant’s product infringes the claims in that family,
- whether a court (or patent office) narrows/invalidates claims,
- and what other patents cover different aspects (active ingredient vs. specific formulations vs. methods).
The key point is that a single WO publication can represent one part of a larger patent family, and generic timing usually depends on the “last blocking” patent(s) in force in the relevant market.
What information should you look for inside WO2010020675?
To understand the practical meaning of WO2010020675 for ribociclib, focus on these sections of the document:
- The claims: what exact thing the applicant says they invented (salt form, polymorph, composition, dosing regimen, synthesis method, etc.).
- The description: the embodiment details that support those claims.
- Priority and family members: earlier priority filings often control the effective date.
- Jurisdictions/countries: WO publications are global filings but national enforcement happens country by country.
If you paste the patent title or claim excerpt from WO2010020675, I can translate it into plain language (what it likely covers) and explain the likely relevance to generics or formulation changes.
Sources
- [1] https://www.drugpatentwatch.com